As of May 01
| +1.05 / +3.54%|
The 2 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 32.00, with a high estimate of 34.00 and a low estimate of 30.00. The median estimate represents a +4.10% increase from the last price of 30.74.
The current consensus among 2 polled investment analysts is to Buy stock in Emergent BioSolutions Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.